Moreover, SAM treatment of rats, during the development of preneoplastic foci, impedes NF-kB activation [51] and stimulates the expression of the oncosuppressor gene PP2A (protein phosphatase 2) and other oncosuppressors that inhibit the progression of preneoplastic nodules to HCC. Here, NFKB1 is linked to hepatocellular carcinoma.